What class is the THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK trademark registered in?

The THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK?

The USPTO serial number for THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK is 97419039.

What is the registration number for THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK?

THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK is registered under USPTO registration number 0.

THE

USPTO Trademark Record

ABANDONED

THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK

SN 97419039·Reg 0·Filed May 19, 2022

Owner The Clinical Trials Network

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK (Serial No. 97419039), Registration No. 0, is a abandoned US trademark filed on May 19, 2022 by The Clinical Trials Network. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK (Reg. #0) is an abandoned US trademark that was filed in 2022 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

May 19, 2022

SERIAL

97419039

REG#

Owner

Applicant

The Clinical Trials Network

Entity

LLC

State

Address

700 W. St. Clair Avenue, Suite #414, Cleveland, OH, 44113

Country

Attorney

NameRobert A. West, Jr.

Law firm

Robert A. West, Jr. Reminger Co., L.P.A.

Docket

09526.0004

Address

200 Public Square, Suite 1200, Cleveland, OH 44114, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMay 19, 2022

Serial Number97419039

Registration No.0

Status DateOct 19, 2023

Mark TypeStandard characters

Attorney Docket09526.0004

Status DescriptionDead and abandoned due to express abandonment

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 01, 2018

First use in commerce: Feb 01, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

ABANDONMENT - EXPRESS MAILED

Oct 19, 2023

ABANDONMENT - EXPRESS MAILED

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

Oct 19, 2023

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

TEAS EXPRESS ABANDONMENT RECEIVED

Oct 16, 2023

TEAS EXPRESS ABANDONMENT RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 10, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 10, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 10, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Sep 10, 2023

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Jun 21, 2023

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Jun 20, 2023

USE AMENDMENT ACCEPTED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Jun 20, 2023

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

May 17, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

AMENDMENT TO USE PROCESSING COMPLETE

May 17, 2023

AMENDMENT TO USE PROCESSING COMPLETE

USE AMENDMENT FILED

May 17, 2023

USE AMENDMENT FILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 16, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS AMENDMENT OF USE RECEIVED

May 16, 2023

TEAS AMENDMENT OF USE RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 16, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Feb 16, 2023

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Feb 16, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 16, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 16, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 25, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

THE ALLERGY/IMMUNOLOGY CLINICAL TRIALS NETWORK

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by The Clinical Trials Network

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Robert A. West, Jr.

Resources

Company